Introduction
Obesity constitutes a major health problem in developed countries, and is increasingly becoming one in the developing world. However, a subset of obese individuals, known as the insulin sensitive (IS) obese or metabolically healthy obese (MHO), maintain insulin sensitivity and exhibit less metabolic abnormalities than their equally obese insulin resistant (IR) counterpart [1, 2] . The transient nature of the protective phenotype of IS obesity, which may shift towards a more adaptable insulin resistant (IR) obesity over time, was previously suggested [3] .
Obesity causes subcutaneous (SC) fat dysfunction, leading to a reduction in the number of differentiating preadipocytes and hypertrophy of mature adipocytes, predisposing adipose tissue to insulin resistance [4] [5] [6] . Obesity-associated insulin resistance is marked by impaired SC adipogenesis while IS obese individuals exhibit a more efficient adipogenesis [7] . This contributes to the expansion of visceral fat in IR obese subjects with ectopic fat deposition in the liver, skeletal muscle and other depots such as epicardial fat [8] , causing further augmentation of IR in these tissues [9] .
Fat accumulation within the adipose tissue correlates with markers of systemic oxidative stress as an early mediator of metabolic syndrome [10] . Increased production of reactive oxygen species (ROS) in the adipose tissue causes lipid peroxidation and tissue dysfunction [10] . One of the ROS main targets are polyunsaturated fatty acids (PUFAs) that are esterified in the membrane or storage lipids [11] . PUFAderived reactive aldehydes have an important role in cellular signaling, proliferation and differentiation, both under physiological as well as pathological conditions [12, 13] . 4-hydroxynonenal (4-HNE) is the most abundant lipid peroxidation product of arachidonic acid and a key mediator of oxidant-induced cell signaling and apoptosis [14] . The cellular concentration of 4-HNE varies from 0.1 to 0.3 µM under physiological conditions and from 10 µM up to 5 mM under oxidative stress [15, 16] . Differences in the redox status and increased 4-HNE levels of human adipose tissues in relation to obesity and metabolic risk were previously reported [17] . This elevation can progressively impair cell structure and function due to the accumulation of stable adducts formed with proteins, phospholipids and DNA [18, 19] . The generation of high levels of 4-HNE has been associated with inflammatory processes [20] [21] [22] through the activation of cyclooxygenase [23] , under pathological conditions such as insulin resistance, atherosclerosis and obesity [24] .
Increased intracellular 4-HNE accumulation in adipose tissues contributes to obesity-related lipolytic activation [25] . The role of 4-HNE on impairment of adipocyte differentiation was shown in 3T3L1 murine preadipocytes, where short-term as well as repeated exposure of these cells to physiological concentrations of 4-HNE promoted subsequent oxidative stress, impaired adipogenesis, alteration of the expression of adipokines, increased lipolytic gene expression and free fatty acids release [26] . These effects were suggested more recently to be mediated by a decrease in aldehyde dehydrogenase 2 activity [27] .
In the present study, we hypothesize that in vitro long-term exposure of SC preadipocytes from IS individuals to 4-HNE can impair their adipogenesis and insulin sensitivity, rendering their behavior like that seen in preadipocytes from IR individuals.
Materials and methods

Materials
IL-6 and leptin ELISAs were purchased from R & D systems (UK) and Insulin ELISA from Mercodia Diagnostics (Sweden). 3,3' Diaminobenzidine tetrahydrochloride and LSAB kit were obtained from DAKO (Denmark). OxiSelect hydrogen peroxide/peroxidase assay kit was obtained from Cell Biolabs (UK). DAPI and LipidTOX™ Green Neutral Lipid were purchased from Life Technologies (UK). Nitrocellulose membranes were obtained from Amersham (UK). Secondary antibody solution EnVision and 3,30-diaminobenzidine tetra-hydrochloride were purchased from Dako (Denmark). Human 4-HNE ELISA kit (CSB-E16214h) was purchased from Cusabio (China). RNAeasy extraction kit, first strand cDNA synthesis kit and RT2 Profiler human insulin resistance PCR arrays were from Qiagen (UK). Milliplex(r) Map Human Panel Oxidative stress Magnetic Bead Panel (H0XSTMAG-18K) was purchased from Millipore (UK) and Bio-Plex Pro™ Cell Signaling Akt Panel, 8-plex (LQ00006JK0K0RR) from BioRad (UK). Other chemicals and reagents were purchased from Sigma (Germany) unless indicated otherwise.
Cohort
Eighteen obese and morbidly obese premenopausal females were recruited among patients undergoing weight reduction surgery at Hamad Medical Corporation (HMC) in Doha, Qatar. All participants provided informed consents before surgery. All protocols were approved by the Institutional Research Boards of ADLQ and HMC (SCH-ADL-070, SCH-JOINT-111). Anthropometric and plasma measures were determined as described previously [7] , including systolic (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MAP), low density lipoprotein (LDL), high density lipoprotein (HDL), total cholesterol, triglycerides, fasting plasma glucose (FPG), IL-6, Leptin, insulin, alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine transaminase (ALT), bilirubin, and total protein. Insulin resistance was calculated by the homeostatic model assessment (HOMA-IR) [28] using 2.4 as a cutoff point (30th percentile). Accordingly, subjects were dichotomized into IS (HOMA-IR < 2.4, 9 subjects) and nondiabetic IR (HOMA-IR > 2.4, 9 subjects). SC adipose tissues of 1-5 g biopsies were collected from all participating subjects during their surgeries and were immediately transported to laboratory for processing.
Immunohistochemical analysis of 4-HNE
Ten adipose tissue samples were randomly selected for immunohistochemical analysis. Adipose tissue biopsies were formalin-fixed and paraffin-embedded. Sections made from paraffin blocks were stained with Hematoxylin/Eosin (HE). 4-HNE staining was performed using our genuine monoclonal antibody specific for HNE-histidine [29, 30] . Monoclonal antibody was obtained from the culture medium of the clone derived from a fusion of Sp2-Ag8 myeloma cells with B-cells of a BALBc mouse immunized with HNE modified keyhole limpet hemocyanine [29] . The clone 1g4h7 TC antibody is specific for the HNEhistidine epitope in HNE-protein (peptide) conjugates. The dot-blot immunochemistry was used to verify the efficiency of monoclonal antibody used for detection of 4-HNE-His adducts by immunohistochemistry. Briefly, the 5% solution of BSA containing final concentrations of 4-HNE ranging from 1 to 100 µM were used for comparison to the control BSA solution without 4-HNE. Two hundred microliters of thus prepared solutions were spotted onto nitrocellulose membranes. Each membrane was incubated in blocking solution (2% non-fat milk powder in phosphate buffer) at room temperature for 60 min and subsequently incubated overnight with mouse monoclonal antibodies against 4-HNE-His adducts. The membranes were afterwards washed and incubated for 30 min with the secondary antibody solution EnVision diluted 1:25 in PBS. Immune complexes were visualized using 3,30-diaminobenzidine tetra-hydrochloride staining.
For the immunohistochemical detection of the HNE-protein adducts the immunoperoxidase technique was used using EnVision kit (Dako, Denmark) as described previously [31] . Briefly, first step included 2 h incubation with monoclonal anti-HNE antibody (dilution 1:10) while the other two steps were performed using EnVision kit according to manufacturers' instructions. 3,3' Diaminobenzidine tetrahydrochloride was used as a chromogen in the HE counterstained sections. Immunohistochemical investigation of HNE positivity was determined by an experienced pathologist without prior knowledge of the experimental groups and scored in a semiquantitative way described before and often used for clinical studies [32] (−0% positive cells, + < 5% positive cells, ++5-25% positive cells, +++25-50% positive cells, ++++ > 50% positive cells). The presence of HNE-protein adducts in adipocytes, connective tissues, inflammatory cells and blood vessels was defined as negative (-) in the absence of the HNE-protein adducts, or as low positive (+, ++) or high positive (+++, ++++) in the presence of the HNE-protein adducts [33] .
Isolation of stromal-vascular fraction cells from human SC adipose tissues
Stromal-vascular fraction (SVF) was obtained by collagenase digestion as previously described [34] . The SVF pellet was re-suspended in stromal medium (DMEM-F12, 10% FBS, Pen/Strep) and maintained in a humidified incubator at 37°C with 5% CO2 until confluence, then passaged at 4×10 4 /cm 2 when necessary.
4-HNE preparation
The aldehyde was obtained in the form of 4-Hydroxynonenaldimethylacetal. Prior to the experiment it was activated with 1 mM cold HCl for 1 h at 4°C. For the experiment HNE was diluted in DMEM-F12 medium.
Proliferation assay
Cells (passage 1-5) were grown in medium (DMEM-F12, Pen/Strep) containing 3% FBS in the absence or presence of different concentrations of 4-HNE ranging from 2.5 to 40 µM for 4 days. Cells were then fixed with formalin for 10 min, stained with 4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI) and total nuclei number quantified by ArrayScan XTI (Thermo Scientific).
Differentiation assays
Cells (passage 1-5) were either grown in differentiation medium (DMEM-F12, 3% FBS, 33 μM bioten, 17 μM D-pantothenate, 1 μM dexamethasone, 250 μM of methylisobutylxanthine, 0.1 μM human insulin, 5 μM of PPARγ agonist, rosiglitazone) in the presence or absence of 5 or 10 μM of 4-HNE for 7 days, followed by 7 days incubation in maintenance medium containing the same components as the differentiation medium except for methylisobutylxanthine and rosiglitazone as described previously [35] . To determine differentiation capacity, cells were fixed with 4% formalin for 10 min, stained with DAPI and subsequently with HCS Lipidtox for 20 min. Total number of nuclei (DAPI) and differentiated adipocytes (Lipidtox positive cells) were scored by ArrayScan XTI (Thermo Scientific) using spot detection module. Differentiation capacity was assessed by calculating the ratio of Lipidtox positive cells/total number of stained nuclei and presented as a percentage (differentiation capacity).
Measuring endogenous 4-HNE protein adduct levels in preadipocyte cultures
Paired cultures of proliferating and differentiating preadipocytes were lysed and endogenous 4-HNE levels were measured in 85 µg protein lysates using human 4-HNE ELISA according to manufacture's instructions.
Gene expression analysis of sterol regulatory element binding transcription factor 1 (SREBF1), fatty acid synthase (FASN) and Fatty acid-binding protein 4 (FABP4) in response to 4-HNE treatment
Preadipocytes were treated with 10 µM 4-HNE every three days for the entire differentiation period. RNA was extracted using RNAeasy kit and cDNA was synthesized using first strand cDNA synthesis kit according to manufacturer's instructions. RT 2 Profiler human insulin resistance PCR arrays were used to simultaneously examine the mRNA levels of 89 genes, including five "housekeeping genes" in 96-well plates according to manufacturer's protocol. Genes included Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1), fatty acid synthase (FASN) and Fatty acid-binding protein 4 (FABP4). Data were normalized with the internal housekeeping genes and ΔΔCt was calculated using ΔCt from proliferating IS-SC as the control group according to manufacturer's protocol.
Adipocyte oxidative stress assay in response to 4-HNE treatment
Intracellular ROS production was evaluated using 2',7'-dichlorfluorescein-diacetate (DCFH-DA, Fluka) probe as previously described [36] . Briefly, cells were pretreated with 10 µM DCFH-DA in the HBSS in 5% CO2/95% air at 37°C for 30 min followed by removal of excess probe and treatment with 5 and 10uM of 4-HNE in stromal medium with 3% FBS. The fluorescence intensity was measured continuously throughout 12 h using TECAN Infinite M200 PRO plate reader equipped with gas control mode to maintain 37°C and 5% CO2, with an excitation wavelength of 500 nm and emission detection at 529 nm. The arbitrary units, relative fluorescence units (RFU), were based directly on fluorescence intensity. Intracellular ROS production was also evaluated using aminotriazole assay as described previously [37] using OxiSelect hydrogen peroxide/peroxidase assay kit following 12 h of 10 µM 4-HNE treatment according to manufacturer's instructions.
Cellular antioxidant defense systems analyses in response to 4-HNE treatment
The effect of 4-HNE treatment on the levels of antioxidant proteins in human preadipocytes was quantified following 1, 4 and 15 days of treatment. Briefly, preadipocytes were treated with 10 µM of 4-HNE one day post-seeding for one day (baseline levels), 4 days (proliferation) or 15 days (differentiation), then lysed and assayed using a commercial human 5-plex Milliplex(r) Map Human Panel Oxidative stress Magnetic Bead Panel (H0XSTMAG-18K) kit following manufacturer's instructions. The panel included catalase, thioredoxin (TRX1), superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2) and peroxiredoxin 2 (PRX2). The assay was performed using Luminex xMAP technology (Merck Millipore) following manufacturer's instructions.
Insulin signaling analysis in response to 4-HNE treatment
The effect of 4-HNE treatment on the phosphorylation of IRS-1 (Ser636/Ser639), p70 S6 kinase (Thr389), GSK-3α/β (Ser21/Ser9) and p70 S6 kinase (Thr389) was quantified in human preadipocytes from IS and IR individuals. Briefly, preadipocytes were treated with 10 µM of 4-HNE one day post-seeding for 15 days then lysed. Equal volumes of lysates were assayed using a commercial Bio-Plex Pro™ Cell Signaling Akt Panel following manufacturer's instructions.
Statistical analysis
Data are presented as mean ± standard deviation (SD) for parametric data, median (interquartile range, IQ) for non-parameteric data in Table 1 and mean ± SEM in figures. Comparisons were performed with t-test, Wilcoxon-Mann-Whitney, 1-way ANOVA, or Linear regression model as appropriate using IBM SPSS statistics 21.
Results
General characteristics of study population
Eighteen obese and morbidly obese (BMI 43.2 ± 5.09 kgm-2) young (30.4 ± 8.3 years) females were recruited from amongst patients undergoing weight reduction surgery at HMC (Table 1) Table 1) .
Characterization of 4-HNE staining in various cell types of the SC adipose tissue from obese patients
To confirm presence of 4-HNE stable adducts in adipose tissues, accumulation of 4-HNE in components of adipose tissues including adipocytes, connective tissues, blood vessels and inflammatory cells was analyzed by immunohistochemistry (IHC) in all tested samples by 4-HNE antibody specific to Histidine epitope (data not shown). The strongest staining of 4-HNE stable adducts was detected in adipocytes and blood vessels; medium staining was in inflammatory cells and weakest staining was in connective tissues (Fig. 1 ). There were no significant differences in 4-HNE staining between IS and IR-adipose tissues confirming previous report [17] .
Measurement of endogenous 4-HNE accumulation in proliferating and differentiating preadipocytes
The presence of 4-HNE adducts in paired cultures of proliferating preadipocytes and differentiated adipocytes was investigated. Detectable concentrations were quantified in both cultures with 30% increase in differentiated adipocytes compared to proliferating preadi- pocytes, possibly as a consequence of lipid accumulation with differentiation. IR differentiating preadipocytes exhibited 20% increase in 4-HNE accumulation than their IS counterparts (Fig. 2) .
Preadipocyte proliferation, ROS generation and levels of ROS scavenging enzymes in response to 4-HNE treatment
The effect of exogenous 4-HNE treatment on preadipocytes growth and differentiation is shown in Fig. 3 . Treatment of preadipocytes with 4-HNE for 4 days exhibited a concentration-dependent inhibition of proliferation at a range of 2.5-20 µM, compared to their untreated control, with higher concentrations causing cell death (Fig. 3A) . Acute treatment of preadipocytes with 10 µM 4-HNE for 12 h caused 2-4 folds elevated intracellular ROS and steady state hydrogen peroxide production compared to untreated cells (p < 0.05, Fig. 3B, C) . It also increased levels of ROS scavenging enzymes including catalase, TRX1, PRX2, SOD1 and SOD2 (Fig. 3D) . Elevated levels of ROS scavenging enzymes were maintained following multiple exposures to 10 µM of 4-HNE for 15 days, except for mitochondrial SOD2 activity (Fig. 3E) . When treated cells were dichotomized into IS and IR, there were no differences in levels of ROS scavenging enzymes in response to short-term (Fig. 3F) nor to long-term 4-HNE treatment except for catalase which exhibited a significantly higher elevation in IS differentiating preadipocytes compared to IR-derived counterparts (Fig. 3G) .
Growth and differentiation of IS vs IR preadipocytes in response to 4-HNE treatment
The effect of long-term treatment with 10 µM of 4-HNE on preadipocyte growth and differentiation in IS and IR cells is presented in Fig. 4 . Exposure to multiple doses of 4-HNE led to reduction in growth and differentiation of preadipocytes in both groups (Fig. 4A) , marked by upregulation of anti-adipogenic FABP4 and down regulation of the adipogenic FASN and SREBF1 genes (Fig. 4B) . Whereas comparable levels of inhibition of cellular growth in response to 4-HNE were detected between IS and IR preadipocytes (Fig. 4C ), 4-HNE had a stronger inhibitory effect on IS-preadipocytes differentiation (p < 0.01) compared to IR with a mean difference of 25.9% (IQR 3.9-55.7) (Fig. 4D) .
Analysis of insulin signaling in IS vs IR preadipocytes in response to 4-HNE treatment
Differences in insulin signaling pathway were detected between IS and IR preadipocytes in response to long-term treatment with 10 µM of 4-HNE (Fig. 5) . IR-derived preadipocytes exhibited lower levels of phosphorylated IRS-1 and 70S6K at baseline compared to IS (Figs. 5A and 5B), confirming their resistance to insulin action. Long-term treatment of preadipocytes from IS subjects to 10 µM of 4-HNE caused significant dephosphorylation of IRS-1 (Fig. 5A) and 70S6K (Fig. 5B) and activation of GSK3α/β (Fig. 5C) and BAD (Fig. 5D ), indicating Fig. 3 . Effect of 4-HNE on SC preadipocytes proliferation and oxidative stress. Proliferation of preadipocytes upon acute exposure to different concentrations of 4-HNE was quantified by automated counting of cell number by DAPI staining (A). Reactive oxygen species (ROS) production was measured in response to 10 µM 4-HNE for up to 12 h compared to untreated (UT) (B). Intracellular levels of hydrogen peroxide measured 12 h upon 10 µM 4-HNE exposure compared to untreated (UT) (C). Levels of ROS scavenging enzymes (catalase, Trx1, Prx2, SOD1 and SOD2) in response to acute (12 h, single exposure) (D) and Long-term (15 days, repeated exposures) treatment of preadipocytes to 10 µM 4-HNE (E). Comparison of levels of ROS scavenging enzymes between insulin sensitive (IS) and insulin resistant (IR)-derived preadipocytes in response to acute (F) and long-term exposures (G). Data are presented as Mean ± SEM in A-E and as median (interquartile range) in F and G. N=18 (9 IS and 9 IR), *P < 0.05, ANOVA and paired samples T-Test.
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development of IR phenotype. On the other hand, 4-HNE treatment of preadipocytes from IR subjects did not cause significant changes in the activation levels of IRS-1, 70S6K, GSK3α/β or BAD, suggesting their adaptation to 4-HNE action.
Discussion
The lipid peroxidation product 4-HNE is one of the key mediators of oxidant-induced cell signaling and apoptosis [14] , as it activates antioxidant defense systems at lower concentrations, while causes increased cell death with higher concentrations [38] . Therefore physiological levels of 4-HNE (up to 10 µM) in adipose tissues play a crucial role in redox homeostasis, whereas elevated 4-HNE levels (above 10 µM) can cause adipocyte dysfunction and insulin resistance [26, 39] . This study reports for the first time that long-term treatment of human primary preadipocytes from SC adipose tissues obtained from obese subjects with physiological concentrations of 4-HNE causes increased oxidative stress, inhibition of cell growth, loss of adipogenic capacity and induction of insulin resistance. The study also reports that preadipocytes from IS subjects are more prone to the effects of 4-HNE treatment than their IR counterpart. The heterogeneity in the sensitivity of SC preadipocytes to 4-HNE with regard to adipogenesis and insulin resistance in obese subjects may reflect the transient status of IS obesity that can change into a more adaptable IR phenotype over time.
Emerging data initially showed that elevated levels of 4-HNE in SC adipose tissues are located mainly within adipocytes and blood vessels in comparable levels between IS and IR subjects. Similar levels of 4-HNE between IS and IR adipose tissues, as reported previously [17] , do not necessarily reflect a similar duration of exposure to 4-HNE as it may merely represent a snapshot of a long processes that preceded the onset of obesity. Indeed, this report shows that spontaneously accumulated levels of 4-HNE adducts are higher in cultured differentiating IRpreadipocytes compared to a similar age IS cultures, perhaps as a result of increased ROS production in IR preadipocytes as we reported previously [7] . This data indeed confirms an important biological role for 4-HNE by showing its spontaneous accumulation in differentiating preadipocytes that alters cellular redox homeostasis.
The data indicated that acute 4-HNE treatment of preadipocytes at a concentration that is at the lower end of the pathophysiological range [15] , and reported previously in 3T3L-1 preadipocytes [26] , increases intracellular hydrogen peroxide as well as ROS production in preadipocytes in a concentration-dependent manner, which is also associated with increased levels of ROS scavenging enzymes including catalase, PRX2, TRX1, SOD1 and SOD2. Acute exposure to 4-HNE had the most pronounced effect on SOD2, suggesting that mitochondria are important early targets for 4-HNE induced redox imbalance in preadipocytes. However, long-term exposure to 4-HNE highlighted the role of catalase, but not SOD2, as the main anti-oxidant defense mechanism in differentiating preadipocytes against oxidative stress mediated by repeated 4-HNE exposure (Fig. 3) . This could be one of the mechanisms triggered to enable cellular adaptation to 4-HNE-induced intracellular H 2 O 2 production [40] . Moreover, elevated catalase could also suggest changes in the lipid metabolism as it is an important enzyme in decomposing H 2 O 2 produced during beta oxidation of fatty acids by flavin adenine dinucleotide (FAD)-oxidases [41] . The increased catalase activity in 4-HNE treated differentiating preadipocytes was more significant in IS-derived cells, suggesting higher sensitivity to 4-HNEinduced oxidative stress, compared to IR-derived counterparts. Taken together, our data confirm both earlier in vitro findings of increased ROS production in response to 4-HNE in 3T3L-1 preadipocyte cell line [26] and in vivo observations of elevated ROS scavenging enzymes in adipose tissues from obese subjects with increased 4-HNE levels [17] , adding to the significant role 4-HNE plays in modulating adipose tissue homeostasis.
Long-term treatment of SC preadipocytes with a physiological concentration of 4-HNE lowered adipogenesis in preadipocytes obtained from both IS and IR individuals, with a greater inhibition in ISderived preadipocytes (Fig. 4) . The important role of 4-HNE in adipogenesis is further supported by gene expression studies of transcriptional regulation of adipocyte differentiation pathway. Key adipogenic genes including pro-adipogenic genes SREBF1 [42, 43] and FASN [44] were down regulated and anti-adipogenic gene FABP4 [45] known to play a role in fatty acid uptake, transport and metabolism was upregulated [46] . The lower susceptibility of IR preadipocytes to 4-HNE damaging effect may suggest that IR preadipocytes have reached a certain degree of adaptation to oxidative stress damage as they developed resistance to insulin. Indeed we have observed that, in response to elevated 4-HNE, IR preadipocytes have higher expression of FABP4 compared to IS preadipocytes (data not shown). In addition to its anti-adipogenic role, FABP4 is a known cellular target [47] and a scavenger of 4-HNE [48] . The IS preadipocytes, on the other hand, were still sensitive to the damaging effect of 4-HNE-induced oxidative stress that may eventually lead to metabolic complications associated with insulin resistance and development of T2DM.
As impaired adipogenesis and subsequent ectopic lipid accumulation are associated with insulin resistance [49] , the greater sensitivity of IS preadipocytes to 4-HNE could also cause impaired glucose homeostasis. Indeed, our data indicated that long-term treatment of IS preadipocytes with a physiological concentration of 4-HNE triggered their resistance to insulin by deactivating the insulin signaling components IRS1 and p70S6K and activating GSK3α/β and BAD that are under the negative control of Akt [50] . As expected, IR-preadipocytes showed no change in their insulin signaling in response to 4-HNE treatment as they are already resistant to its actions as seen at baseline. Although previous reports have shown that 4-HNE can induce insulin resistance in skeletal muscle cells [39] , this is the first report of induction of insulin resistance in human SC differentiating preadipocytes in response to 4-HNE. Taken together, Fig. 6 depicts proposed actions for 4-HNE in differentiating preadipocytes. Previous studies have shown that abolishing 4-HNE-induced oxidative stress in 3T3L1 by pharmacological intervention leads to lowering inflammation-related cyclooxygenase expression [23] , reversal of 4-HNE deleterious effects and improvement in insulin sensitivity [51] . Future work will focus on pharmacological intervention aimed at alleviating insulin resistance and oxidative stress in IR preadipocytes.
Conclusions
In conclusion, this study provides novel evidence for 4-HNEmediated inhibition of human preadipocytes growth, impairment of adipogenesis and induction of insulin resistance, thus highlighting its crucial role in the progression obesity-associated metabolic syndrome. The data also identifies 4-HNE as a key player in the pathophysiology of adipose tissue in IS obesity and potentially a therapeutic target before progression into IR obesity.
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